Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 99.62 million. The enterprise value is -10.50 million.

Market Cap	99.62M
Enterprise Value	-10.50M

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.34M
Shares Outstanding	n/a
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	0.61
P/TBV Ratio	0.61
P/FCF Ratio	9.56
P/OCF Ratio	6.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.01

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.07.

Current Ratio	3.52
Quick Ratio	2.72
Debt / Equity	0.07
Debt / EBITDA	0.61
Debt / FCF	1.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.32% and return on invested capital (ROIC) is 1.69%.

Return on Equity (ROE)	-3.32%
Return on Assets (ROA)	1.33%
Return on Invested Capital (ROIC)	1.69%
Return on Capital Employed (ROCE)	2.82%
Revenue Per Employee	834,576
Profits Per Employee	-10,745
Employee Count	504
Asset Turnover	1.87
Inventory Turnover	3.31

Taxes

Income Tax	-212,847
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.10% in the last 52 weeks. The beta is 0.89, so Medifast's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-34.10%
50-Day Moving Average	13.08
200-Day Moving Average	16.01
Relative Strength Index (RSI)	47.54
Average Volume (20 Days)	206

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.78

Income Statement

In the last 12 months, Medifast had revenue of GBP 420.63 million and -5.42 million in losses. Loss per share was -0.50.

Revenue	420.63M
Gross Profit	310.82M
Operating Income	4.78M
Pretax Income	-5.63M
Net Income	-5.42M
EBITDA	14.63M
EBIT	4.78M
Loss Per Share	-0.50

Full Income Statement

Balance Sheet

The company has 127.39 million in cash and 11.31 million in debt, giving a net cash position of 116.09 million.

Cash & Cash Equivalents	127.39M
Total Debt	11.31M
Net Cash	116.09M
Net Cash Per Share	n/a
Equity (Book Value)	163.28M
Book Value Per Share	15.79
Working Capital	118.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.94 million and capital expenditures -5.52 million, giving a free cash flow of 10.42 million.

Operating Cash Flow	15.94M
Capital Expenditures	-5.52M
Free Cash Flow	10.42M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.89%, with operating and profit margins of 1.14% and -1.29%.

Gross Margin	73.89%
Operating Margin	1.14%
Pretax Margin	-1.34%
Profit Margin	-1.29%
EBITDA Margin	3.48%
EBIT Margin	1.14%
FCF Margin	2.48%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	n/a
Earnings Yield	-5.44%
FCF Yield	10.46%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 5.4 and a Piotroski F-Score of 5.

Altman Z-Score	5.4
Piotroski F-Score	5